nodes	percent_of_prediction	percent_of_DWPC	metapath
Mercaptopurine—SLC28A2—renal system—cervical cancer	0.0884	0.0972	CbGeAlD
Mercaptopurine—PPAT—uterine cervix—cervical cancer	0.0233	0.0257	CbGeAlD
Mercaptopurine—SLC28A3—mammalian vulva—cervical cancer	0.0232	0.0255	CbGeAlD
Mercaptopurine—PPAT—endometrium—cervical cancer	0.0211	0.0232	CbGeAlD
Mercaptopurine—PPAT—mammalian vulva—cervical cancer	0.0204	0.0224	CbGeAlD
Mercaptopurine—SLC29A2—female reproductive system—cervical cancer	0.0182	0.02	CbGeAlD
Mercaptopurine—SLC28A3—female gonad—cervical cancer	0.0181	0.0199	CbGeAlD
Mercaptopurine—HPRT1—uterine cervix—cervical cancer	0.0179	0.0197	CbGeAlD
Mercaptopurine—XDH—uterine cervix—cervical cancer	0.0177	0.0194	CbGeAlD
Mercaptopurine—PPAT—female reproductive system—cervical cancer	0.0175	0.0192	CbGeAlD
Mercaptopurine—HPRT1—decidua—cervical cancer	0.0171	0.0188	CbGeAlD
Mercaptopurine—HPRT1—renal system—cervical cancer	0.0168	0.0184	CbGeAlD
Mercaptopurine—XDH—renal system—cervical cancer	0.0165	0.0182	CbGeAlD
Mercaptopurine—SLC29A2—vagina—cervical cancer	0.0164	0.0181	CbGeAlD
Mercaptopurine—HPRT1—endometrium—cervical cancer	0.0162	0.0178	CbGeAlD
Mercaptopurine—XDH—endometrium—cervical cancer	0.016	0.0176	CbGeAlD
Mercaptopurine—Myelosuppression—Topotecan—cervical cancer	0.0159	0.176	CcSEcCtD
Mercaptopurine—PPAT—female gonad—cervical cancer	0.0159	0.0175	CbGeAlD
Mercaptopurine—PPAT—vagina—cervical cancer	0.0158	0.0174	CbGeAlD
Mercaptopurine—HPRT1—mammalian vulva—cervical cancer	0.0157	0.0172	CbGeAlD
Mercaptopurine—XDH—mammalian vulva—cervical cancer	0.0155	0.017	CbGeAlD
Mercaptopurine—TPMT—uterine cervix—cervical cancer	0.0151	0.0166	CbGeAlD
Mercaptopurine—HPRT1—uterus—cervical cancer	0.0149	0.0164	CbGeAlD
Mercaptopurine—TPMT—decidua—cervical cancer	0.0144	0.0158	CbGeAlD
Mercaptopurine—TPMT—renal system—cervical cancer	0.0141	0.0155	CbGeAlD
Mercaptopurine—TPMT—endometrium—cervical cancer	0.0137	0.015	CbGeAlD
Mercaptopurine—HPRT1—female reproductive system—cervical cancer	0.0134	0.0147	CbGeAlD
Mercaptopurine—XDH—female reproductive system—cervical cancer	0.0133	0.0146	CbGeAlD
Mercaptopurine—TPMT—mammalian vulva—cervical cancer	0.0132	0.0145	CbGeAlD
Mercaptopurine—ABCC5—uterine cervix—cervical cancer	0.0131	0.0144	CbGeAlD
Mercaptopurine—ABCC5—decidua—cervical cancer	0.0125	0.0137	CbGeAlD
Mercaptopurine—HPRT1—female gonad—cervical cancer	0.0122	0.0134	CbGeAlD
Mercaptopurine—HPRT1—vagina—cervical cancer	0.0121	0.0133	CbGeAlD
Mercaptopurine—SLC29A1—uterine cervix—cervical cancer	0.012	0.0132	CbGeAlD
Mercaptopurine—XDH—vagina—cervical cancer	0.012	0.0132	CbGeAlD
Mercaptopurine—SLC29A1—decidua—cervical cancer	0.0115	0.0126	CbGeAlD
Mercaptopurine—SLC29A1—renal system—cervical cancer	0.0112	0.0124	CbGeAlD
Mercaptopurine—AOX1—uterine cervix—cervical cancer	0.0112	0.0124	CbGeAlD
Mercaptopurine—SLC29A1—endometrium—cervical cancer	0.0109	0.012	CbGeAlD
Mercaptopurine—AOX1—decidua—cervical cancer	0.0107	0.0118	CbGeAlD
Mercaptopurine—SLC29A2—lymph node—cervical cancer	0.0106	0.0117	CbGeAlD
Mercaptopurine—SLC29A1—mammalian vulva—cervical cancer	0.0105	0.0116	CbGeAlD
Mercaptopurine—AOX1—renal system—cervical cancer	0.0105	0.0116	CbGeAlD
Mercaptopurine—TPMT—female gonad—cervical cancer	0.0103	0.0113	CbGeAlD
Mercaptopurine—TPMT—vagina—cervical cancer	0.0102	0.0112	CbGeAlD
Mercaptopurine—PPAT—lymph node—cervical cancer	0.0102	0.0112	CbGeAlD
Mercaptopurine—AOX1—endometrium—cervical cancer	0.0102	0.0112	CbGeAlD
Mercaptopurine—SLC29A1—uterus—cervical cancer	0.01	0.011	CbGeAlD
Mercaptopurine—AOX1—mammalian vulva—cervical cancer	0.00983	0.0108	CbGeAlD
Mercaptopurine—AOX1—uterus—cervical cancer	0.00937	0.0103	CbGeAlD
Mercaptopurine—SLC29A1—female reproductive system—cervical cancer	0.00901	0.0099	CbGeAlD
Mercaptopurine—ABCC5—female gonad—cervical cancer	0.00893	0.00981	CbGeAlD
Mercaptopurine—ABCC5—vagina—cervical cancer	0.00887	0.00975	CbGeAlD
Mercaptopurine—ABCC4—renal system—cervical cancer	0.00849	0.00933	CbGeAlD
Mercaptopurine—SLC22A8—renal system—cervical cancer	0.00842	0.00926	CbGeAlD
Mercaptopurine—AOX1—female reproductive system—cervical cancer	0.00842	0.00926	CbGeAlD
Mercaptopurine—SLC29A1—female gonad—cervical cancer	0.00819	0.00901	CbGeAlD
Mercaptopurine—SLC29A1—vagina—cervical cancer	0.00814	0.00895	CbGeAlD
Mercaptopurine—HPRT1—lymph node—cervical cancer	0.00785	0.00863	CbGeAlD
Mercaptopurine—AOX1—female gonad—cervical cancer	0.00766	0.00842	CbGeAlD
Mercaptopurine—AOX1—vagina—cervical cancer	0.00762	0.00837	CbGeAlD
Mercaptopurine—ABCC4—uterus—cervical cancer	0.00756	0.00832	CbGeAlD
Mercaptopurine—ABCC4—female reproductive system—cervical cancer	0.0068	0.00748	CbGeAlD
Mercaptopurine—Neoplasm—Topotecan—cervical cancer	0.00675	0.0747	CcSEcCtD
Mercaptopurine—TPMT—lymph node—cervical cancer	0.00662	0.00728	CbGeAlD
Mercaptopurine—Sepsis—Topotecan—cervical cancer	0.00648	0.0717	CcSEcCtD
Mercaptopurine—ABCC4—female gonad—cervical cancer	0.00619	0.0068	CbGeAlD
Mercaptopurine—ABCC5—lymph node—cervical cancer	0.00574	0.00631	CbGeAlD
Mercaptopurine—SLC29A1—lymph node—cervical cancer	0.00527	0.00579	CbGeAlD
Mercaptopurine—AOX1—lymph node—cervical cancer	0.00493	0.00542	CbGeAlD
Mercaptopurine—Pancytopenia—Topotecan—cervical cancer	0.00445	0.0492	CcSEcCtD
Mercaptopurine—Stomatitis—Topotecan—cervical cancer	0.00407	0.045	CcSEcCtD
Mercaptopurine—ABCC4—lymph node—cervical cancer	0.00398	0.00437	CbGeAlD
Mercaptopurine—Hepatobiliary disease—Topotecan—cervical cancer	0.00395	0.0437	CcSEcCtD
Mercaptopurine—Immune system disorder—Topotecan—cervical cancer	0.00339	0.0375	CcSEcCtD
Mercaptopurine—Alopecia—Topotecan—cervical cancer	0.00332	0.0367	CcSEcCtD
Mercaptopurine—Malnutrition—Topotecan—cervical cancer	0.00327	0.0361	CcSEcCtD
Mercaptopurine—Anaemia—Topotecan—cervical cancer	0.00302	0.0334	CcSEcCtD
Mercaptopurine—Leukopenia—Topotecan—cervical cancer	0.00292	0.0323	CcSEcCtD
Mercaptopurine—Arthralgia—Topotecan—cervical cancer	0.00278	0.0307	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00276	0.0305	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Topotecan—cervical cancer	0.00261	0.0289	CcSEcCtD
Mercaptopurine—Skin disorder—Topotecan—cervical cancer	0.00259	0.0286	CcSEcCtD
Mercaptopurine—Anorexia—Topotecan—cervical cancer	0.00254	0.0281	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00243	0.0269	CcSEcCtD
Mercaptopurine—Decreased appetite—Topotecan—cervical cancer	0.00232	0.0256	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Topotecan—cervical cancer	0.0023	0.0254	CcSEcCtD
Mercaptopurine—Body temperature increased—Topotecan—cervical cancer	0.00211	0.0233	CcSEcCtD
Mercaptopurine—Hypersensitivity—Topotecan—cervical cancer	0.00196	0.0217	CcSEcCtD
Mercaptopurine—Diarrhoea—Topotecan—cervical cancer	0.00182	0.0202	CcSEcCtD
Mercaptopurine—Vomiting—Topotecan—cervical cancer	0.00169	0.0187	CcSEcCtD
Mercaptopurine—Rash—Topotecan—cervical cancer	0.00168	0.0186	CcSEcCtD
Mercaptopurine—Dermatitis—Topotecan—cervical cancer	0.00168	0.0186	CcSEcCtD
Mercaptopurine—Nausea—Topotecan—cervical cancer	0.00158	0.0175	CcSEcCtD
